Marius F. W. Trollmann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Marius F. W. Trollmann has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Rainer A. Böckmann
Computational Biology, Department of Biology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
12 shared publications Paolo Rossetti
Computational Biology, Department of Biology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
3 shared publications- Paolo Rossetti
Computational Biology, Department of Biology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
3 shared publications - Christian Eggeling
Leibniz Institute of Photonic Technology (IPHT)
2 shared publications Christina Wichmann
Institute of Applied Optics and Biophysics Friedrich‐Schiller University Jena 07743 Jena Germany
1 shared publication- Christina Wichmann
Friedrich Schiller University Jena
1 shared publication
Latest Publications
- Open Access
Large phospholipid-number asymmetry is not required to reproduce plasma membrane physical properties
Plasma membranes are compositionally asymmetric, but whether this lipid-type asymmetry is accompanied by a substantial phospholipid-number imbalance between leaflets remains debated. Here, we use microsecond all-atom molecular dynamics simulations to compare human red blood cell plasma membrane models with either strong phospholipid-number asymmetry and exoplasmic cholesterol enrichment or near-symmetric phospholipid and cholesterol numbers but preserved lipid-type asymmetry. Both asymmetric models reproduce a densely packed, ordered exoplasmic leaflet and a more fluid cytoplasmic leaflet. Strong phospholipid-number asymmetry, however, drives extensive cholesterol enrichment in the exoplasmic leaflet and amplifies membrane asymmetry, leading to large cholesterol-rich clusters, enhanced shallow hydrophobic exposure, reduced exoplasmic lipid mobility, lower ethanol permeability, and increased area compressibility. Comparison with available diffusion and alcohol-permeability measurements indicates that the strongly asymmetric model overestimates the immobilization and barrier properties of the exoplasmic leaflet, whereas the near-symmetric-number model better captures these dynamic observables. Our results suggest that lipid-type asymmetry is sufficient to reproduce many physical hallmarks of plasma membranes without requiring a large phospholipid-number imbalance.
Open AccessLarge phospholipid-number asymmetry is not required to reproduce plasma membrane physical properties
Plasma membranes are compositionally asymmetric, but whether this lipid-type asymmetry is accompanied by a substantial phospholipid-number imbalance between leaflets remains debated. Here, we use microsecond all-atom molecular dynamics simulations to compare human red blood cell plasma membrane models with either strong phospholipid-number asymmetry and exoplasmic cholesterol enrichment or near-symmetric phospholipid and cholesterol numbers but preserved lipid-type asymmetry. Both asymmetric models reproduce a densely packed, ordered exoplasmic leaflet and a more fluid cytoplasmic leaflet. Strong phospholipid-number asymmetry, however, drives extensive cholesterol enrichment in the exoplasmic leaflet and amplifies membrane asymmetry, leading to large cholesterol-rich clusters, enhanced shallow hydrophobic exposure, reduced exoplasmic lipid mobility, lower ethanol permeability, and increased area compressibility. Comparison with available diffusion and alcohol-permeability measurements indicates that the strongly asymmetric model overestimates the immobilization and barrier properties of the exoplasmic leaflet, whereas the near-symmetric-number model better captures these dynamic observables. Our results suggest that lipid-type asymmetry is sufficient to reproduce many physical hallmarks of plasma membranes without requiring a large phospholipid-number imbalance.
- Open Access
- 26 June 2026
- Published by Elsevier in Biophysical Journal
- Vol. 125 (15) , 3918-3937
Membrane environment sets the functional pKa of ionizable lipids
- 26 June 2026
- Published by Elsevier in Biophysical Journal
- Vol. 125 (15) , 3918-3937
Open AccessMembrane environment sets the functional pKa of ionizable lipids
- Open Access
Membrane Environment Sets the Functional pK a of Ionizable Lipids
Ionizable aminolipids enable lipid nanoparticles (LNPs) to encapsulate nucleic acids at neutral pH and to release their cargo upon endosomal acidification. The discrepancy between this effective, acidic LNP pK a and the basic intrinsic pK a of aminolipids, however, remains poorly understood. Here, we performed microsecond constant-pH molecular dynamics simulations of five widely used aminolipids (DODAP, DLin-MC3-DMA, DLin-KC2-DMA, ALC-0315, and SM-102) embedded in different LNP-relevant ternary DOPC/D-SPC–cholesterol membranes to quantify how aminolipid structure and membrane composition jointly govern aminolipid protonation and the associated pH-dependent membrane remodeling. Across all systems, membrane embedding lowers the apparent aminolipid pK a , yielding physiologically relevant values of 6–7.5 corresponding to shifts by up to 3.5 pK a units or approx. 20 kJ mol − 1 with respect to the intrinsic pK a . Strikingly, the magnitude of the pK a shift correlates with pH-driven membrane remodeling upon deprotonation: polyunsaturated aminolipids undergo surface-to-core translocation, branched aminolipids preferentially form laterally segregated surface domains, and DODAP remains interfacially anchored through sustained hydration and hydrogen bonding. Saturated helper lipids (DSPC) systematically enhance segregation and amplify pK a shifts relative to DOPC. Together, these results identify membrane phase behavior as a primary regulator of aminolipid protonation equilibria and establish quantitative design principles for tuning LNP composition toward desired pK a , membrane remodeling, and delivery performance.
Open AccessMembrane Environment Sets the Functional pK a of Ionizable Lipids
Ionizable aminolipids enable lipid nanoparticles (LNPs) to encapsulate nucleic acids at neutral pH and to release their cargo upon endosomal acidification. The discrepancy between this effective, acidic LNP pK a and the basic intrinsic pK a of aminolipids, however, remains poorly understood. Here, we performed microsecond constant-pH molecular dynamics simulations of five widely used aminolipids (DODAP, DLin-MC3-DMA, DLin-KC2-DMA, ALC-0315, and SM-102) embedded in different LNP-relevant ternary DOPC/D-SPC–cholesterol membranes to quantify how aminolipid structure and membrane composition jointly govern aminolipid protonation and the associated pH-dependent membrane remodeling. Across all systems, membrane embedding lowers the apparent aminolipid pK a , yielding physiologically relevant values of 6–7.5 corresponding to shifts by up to 3.5 pK a units or approx. 20 kJ mol − 1 with respect to the intrinsic pK a . Strikingly, the magnitude of the pK a shift correlates with pH-driven membrane remodeling upon deprotonation: polyunsaturated aminolipids undergo surface-to-core translocation, branched aminolipids preferentially form laterally segregated surface domains, and DODAP remains interfacially anchored through sustained hydration and hydrogen bonding. Saturated helper lipids (DSPC) systematically enhance segregation and amplify pK a shifts relative to DOPC. Together, these results identify membrane phase behavior as a primary regulator of aminolipid protonation equilibria and establish quantitative design principles for tuning LNP composition toward desired pK a , membrane remodeling, and delivery performance.
- Open Access
From Membrane Composition to Antimicrobial Strategies: Experimental and Computational Approaches to AMP Design and Selectivity
The United Nations have committed to end the epidemics of communicable diseases by 2030 (SDG Target 3.3). In contrast with this ambition, the rise of Multi Drug Resistant (MDR) and Pan Drug Resistant (PDR) bacteria poses a threat of a return to the pre‐antibiotic era. It is of high priority to find new therapies that target the ESKAPEE group of pathogens and their drug‐resistant strains. Antimicrobial peptides (AMPs) are an emerging class of antibiotics that hold promises of overcoming bacterial resistance by using both novel mechanisms of action as well as targeting already known pathways. The chemical space of AMPs is potentially huge and methodologies allowing the rational exploration of novel structures are highly needed. This review focuses on case studies that give novel insights about the mechanisms of action, resistance and selectivity of some relevant AMPs, exemplifying the importance of microscopic, computational and experimental tools. Particular focus will be devoted to bacterial membranes and how AMPs can target them while sparing human plasma membranes, in order to become safer drugs. The lessons learned from the literature cases give directions toward the development of AMPs as drug products.
Open AccessFrom Membrane Composition to Antimicrobial Strategies: Experimental and Computational Approaches to AMP Design and Selectivity
The United Nations have committed to end the epidemics of communicable diseases by 2030 (SDG Target 3.3). In contrast with this ambition, the rise of Multi Drug Resistant (MDR) and Pan Drug Resistant (PDR) bacteria poses a threat of a return to the pre‐antibiotic era. It is of high priority to find new therapies that target the ESKAPEE group of pathogens and their drug‐resistant strains. Antimicrobial peptides (AMPs) are an emerging class of antibiotics that hold promises of overcoming bacterial resistance by using both novel mechanisms of action as well as targeting already known pathways. The chemical space of AMPs is potentially huge and methodologies allowing the rational exploration of novel structures are highly needed. This review focuses on case studies that give novel insights about the mechanisms of action, resistance and selectivity of some relevant AMPs, exemplifying the importance of microscopic, computational and experimental tools. Particular focus will be devoted to bacterial membranes and how AMPs can target them while sparing human plasma membranes, in order to become safer drugs. The lessons learned from the literature cases give directions toward the development of AMPs as drug products.
- Open Access
- 2 June 2025
- Published by American Chemical Society (ACS) in ChemRxiv
From Membrane Composition to Antimicrobial Strategies: Experimental and Computational Approaches to AMP Design and Selectivity
The United Nations have committed to end the epidemics of communicable diseases by 2030 (SDG Target 3.3). In contrast with this ambition, the rise of Multi Drug Resistant (MDR) and Pan Drug Resistant (PDR) bacteria poses a threat of a return to the pre-antibiotic era. It is of high priority to find new therapies that target the ESKAPEE group of pathogens and their drug-resistant strains. Antimicrobial peptides (AMPs) are an emerging class of antibiotics that hold promises of overcoming bacterial resistance by using both novel mechanisms of action as well as targeting already known pathways. The chemical space of AMPs is potentially huge and methodologies allowing the rational exploration of novel structures are highly needed. This review focuses on case studies that give novel insights about the mechanisms of action, resistance and selectivity of some relevant AMPs, exemplifying the importance of microscopic, computational and experimental tools. Particular focus will be devoted to bacterial membranes, and how AMPs can target them while sparing human plasma membranes, in order to become safer drugs. The lessons learned from the literature cases give directions towards the development of AMPs as drug products.
- 2 June 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessFrom Membrane Composition to Antimicrobial Strategies: Experimental and Computational Approaches to AMP Design and Selectivity
The United Nations have committed to end the epidemics of communicable diseases by 2030 (SDG Target 3.3). In contrast with this ambition, the rise of Multi Drug Resistant (MDR) and Pan Drug Resistant (PDR) bacteria poses a threat of a return to the pre-antibiotic era. It is of high priority to find new therapies that target the ESKAPEE group of pathogens and their drug-resistant strains. Antimicrobial peptides (AMPs) are an emerging class of antibiotics that hold promises of overcoming bacterial resistance by using both novel mechanisms of action as well as targeting already known pathways. The chemical space of AMPs is potentially huge and methodologies allowing the rational exploration of novel structures are highly needed. This review focuses on case studies that give novel insights about the mechanisms of action, resistance and selectivity of some relevant AMPs, exemplifying the importance of microscopic, computational and experimental tools. Particular focus will be devoted to bacterial membranes, and how AMPs can target them while sparing human plasma membranes, in order to become safer drugs. The lessons learned from the literature cases give directions towards the development of AMPs as drug products.
- Open Access
Constant-pH MD Simulations of Lipids
Constant pH Molecular Dynamics (CpHMD) simulations represent a cutting-edge computational approach for studying biological systems with remarkable realism. Recent advancements have enhanced the accessibility and efficiency of CpHMD, significantly reducing the performance overhead compared to traditional constant-protonation MD simulations. This chapter guides the reader through the application of CpHMD to investigate the pH-dependent behavior of Cationic Ionizable Lipids (CILs) — a critical component of Lipid Nanoparticles (LNPs), which are among the most promising platforms for drug delivery. LNPs, including those employed in mRNA-based vaccines, played a pivotal role in the global response to the SARS-CoV-2 pandemic, underscoring their potential in modern medicine. The chapter begins with a comprehensive introduction to the fundamental concepts of LNPs and provides a step-by-step protocol for setting up simulations of membranes containing CILs to calculate their apparent pK a . This parameter is crucial for governing the in vivo behavior of LNPs, where precise control is essential to optimize delivery efficiency while minimizing toxicity. By showcasing the ability of CpHMD simulations to unravel the intricate relationship between pH-dependent protonation, membrane structure, and lipid distribution, this chapter highlights their potential to inform the rational design of novel LNP formulations.
Open AccessConstant-pH MD Simulations of Lipids
Constant pH Molecular Dynamics (CpHMD) simulations represent a cutting-edge computational approach for studying biological systems with remarkable realism. Recent advancements have enhanced the accessibility and efficiency of CpHMD, significantly reducing the performance overhead compared to traditional constant-protonation MD simulations. This chapter guides the reader through the application of CpHMD to investigate the pH-dependent behavior of Cationic Ionizable Lipids (CILs) — a critical component of Lipid Nanoparticles (LNPs), which are among the most promising platforms for drug delivery. LNPs, including those employed in mRNA-based vaccines, played a pivotal role in the global response to the SARS-CoV-2 pandemic, underscoring their potential in modern medicine. The chapter begins with a comprehensive introduction to the fundamental concepts of LNPs and provides a step-by-step protocol for setting up simulations of membranes containing CILs to calculate their apparent pK a . This parameter is crucial for governing the in vivo behavior of LNPs, where precise control is essential to optimize delivery efficiency while minimizing toxicity. By showcasing the ability of CpHMD simulations to unravel the intricate relationship between pH-dependent protonation, membrane structure, and lipid distribution, this chapter highlights their potential to inform the rational design of novel LNP formulations.
- Open Access
Revisiting Lipid Nanoparticle Composition and Structure: A Critical Take on Simulation Approaches
Comment to article published in Proc. Natl. Acad. Sci. U. S. A.: Garaizar, A. et al. 'Toward understanding lipid reorganization in RNA lipid nanoparticles in acidic environments.' Proc. Natl. Acad. Sci. U. S. A. 121, e2404555121 (2024)
Open AccessRevisiting Lipid Nanoparticle Composition and Structure: A Critical Take on Simulation Approaches
Comment to article published in Proc. Natl. Acad. Sci. U. S. A.: Garaizar, A. et al. 'Toward understanding lipid reorganization in RNA lipid nanoparticles in acidic environments.' Proc. Natl. Acad. Sci. U. S. A. 121, e2404555121 (2024)
- Open Access
Decoding pH-Driven Phase Transition of Lipid Nanoparticles
The functionality of lipid nanoparticles (LNPs) as delivery systems in mRNA-based therapeutics is intricately linked to the protonation behavior of their aminolipid components. This study employs large-scale constant-pH molecular dynamics (CpHMD) simulations to decode the environment-dependent pK a of aminolipids in the Comirnaty lipid formulation, providing a detailed view of their pH-dependent structural dynamics. Our results reveal a significant shift in the apparent pK a of the aminolipid ALC-0315, from an intrinsic value of 9.3 in water to 4.9 within the LNP environment. This shift arises from the interplay between lipid reorganization and local electrostatic interactions, resulting in distinct protonation states across the LNP core and surface. At low pH, protonated aminolipids dominate the LNP surface, promoting efficient mRNA encapsulation, whereas at neutral pH, deprotonated aminolipids migrate to the hydrophobic core, driving structural stabilization. Notably, the localized pK a of aminolipids varies significantly with their position, decreasing from near-surface regions (7 to 8) to the hydrophobic core (≤4). These findings elucidate the molecular mechanisms underpinning LNP phase transitions and highlight the key role of pK a shifts for the design of aminolipids and for optimizing LNP compositions for enhanced therapeutic delivery. This study bridges experimental observations with molecular-level insights, advancing the rational development of next-generation lipid-based nanocarriers.
Open AccessDecoding pH-Driven Phase Transition of Lipid Nanoparticles
The functionality of lipid nanoparticles (LNPs) as delivery systems in mRNA-based therapeutics is intricately linked to the protonation behavior of their aminolipid components. This study employs large-scale constant-pH molecular dynamics (CpHMD) simulations to decode the environment-dependent pK a of aminolipids in the Comirnaty lipid formulation, providing a detailed view of their pH-dependent structural dynamics. Our results reveal a significant shift in the apparent pK a of the aminolipid ALC-0315, from an intrinsic value of 9.3 in water to 4.9 within the LNP environment. This shift arises from the interplay between lipid reorganization and local electrostatic interactions, resulting in distinct protonation states across the LNP core and surface. At low pH, protonated aminolipids dominate the LNP surface, promoting efficient mRNA encapsulation, whereas at neutral pH, deprotonated aminolipids migrate to the hydrophobic core, driving structural stabilization. Notably, the localized pK a of aminolipids varies significantly with their position, decreasing from near-surface regions (7 to 8) to the hydrophobic core (≤4). These findings elucidate the molecular mechanisms underpinning LNP phase transitions and highlight the key role of pK a shifts for the design of aminolipids and for optimizing LNP compositions for enhanced therapeutic delivery. This study bridges experimental observations with molecular-level insights, advancing the rational development of next-generation lipid-based nanocarriers.
- Open Access
- 30 September 2024
- Published by Springer Nature in Research Square
DomHMM – Analysis of Membrane Domains
Lateral nano- or microdomains are a major hallmark of biological membranes. A key challenge in analyzing membrane domains from molecular dynamics (MD) simulations lies in accurately assigning lipids to more ordered (Lo) or disordered (Ld) membrane domains, particularly when these domains exhibit similar chemical compositions but differ in structural characteristics. To address this issue, we present the implementation of DomHMM, a novel application previously developed for the unsupervised classification of Lo and Ld domains based on coarse-grained or all-atom MD simulations. DomHMM employs a Gaussian-based Hidden MarkovModel (HMM) for initial lipid state assignment based on specific lipid characteristics, followed by state reweighing through local spatial correlations andsubsequent clustering. This approach significantly improves the efficiency and accuracy of membrane domain analysis, establishing DomHMM as a robust tool for investigating membrane domain behavior.
- 30 September 2024
- Published by Springer Nature in Research Square
Open AccessDomHMM – Analysis of Membrane Domains
Lateral nano- or microdomains are a major hallmark of biological membranes. A key challenge in analyzing membrane domains from molecular dynamics (MD) simulations lies in accurately assigning lipids to more ordered (Lo) or disordered (Ld) membrane domains, particularly when these domains exhibit similar chemical compositions but differ in structural characteristics. To address this issue, we present the implementation of DomHMM, a novel application previously developed for the unsupervised classification of Lo and Ld domains based on coarse-grained or all-atom MD simulations. DomHMM employs a Gaussian-based Hidden MarkovModel (HMM) for initial lipid state assignment based on specific lipid characteristics, followed by state reweighing through local spatial correlations andsubsequent clustering. This approach significantly improves the efficiency and accuracy of membrane domain analysis, establishing DomHMM as a robust tool for investigating membrane domain behavior.
- Open Access
- 25 April 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-16
The antimicrobial fibupeptide lugdunin forms water-filled channel structures in lipid membranes
Recently, a novel cyclo-heptapeptide composed of alternating d,l-amino acids and a unique thiazolidine heterocycle, called lugdunin, was discovered, which is produced by the nasal and skin commensal Staphylococcus lugdunensis. Lugdunin displays potent antimicrobial activity against a broad spectrum of Gram-positive bacteria, including challenging-to-treat methicillin-resistant Staphylococcus aureus (MRSA). Lugdunin specifically inhibits target bacteria by dissipating their membrane potential. However, the precise mode of action of this new class of fibupeptides remains largely elusive. Here, we disclose the mechanism by which lugdunin rapidly destabilizes the bacterial membrane potential using an in vitro approach. The peptide strongly partitions into lipid compositions resembling Gram-positive bacterial membranes but less in those harboring the eukaryotic membrane component cholesterol. Upon insertion, lugdunin forms hydrogen-bonded antiparallel β-sheets by the formation of peptide nanotubes, as demonstrated by ATR-FTIR spectroscopy and molecular dynamics simulations. These hydrophilic nanotubes filled with a water wire facilitate not only the translocation of protons but also of monovalent cations as demonstrated by voltage-clamp experiments on black lipid membranes. Collectively, our results provide evidence that the natural fibupeptide lugdunin acts as a peptidic channel that is spontaneously formed by an intricate stacking mechanism, leading to the dissipation of a bacterial cell’s membrane potential.
- 25 April 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-16
Open AccessThe antimicrobial fibupeptide lugdunin forms water-filled channel structures in lipid membranes
Recently, a novel cyclo-heptapeptide composed of alternating d,l-amino acids and a unique thiazolidine heterocycle, called lugdunin, was discovered, which is produced by the nasal and skin commensal Staphylococcus lugdunensis. Lugdunin displays potent antimicrobial activity against a broad spectrum of Gram-positive bacteria, including challenging-to-treat methicillin-resistant Staphylococcus aureus (MRSA). Lugdunin specifically inhibits target bacteria by dissipating their membrane potential. However, the precise mode of action of this new class of fibupeptides remains largely elusive. Here, we disclose the mechanism by which lugdunin rapidly destabilizes the bacterial membrane potential using an in vitro approach. The peptide strongly partitions into lipid compositions resembling Gram-positive bacterial membranes but less in those harboring the eukaryotic membrane component cholesterol. Upon insertion, lugdunin forms hydrogen-bonded antiparallel β-sheets by the formation of peptide nanotubes, as demonstrated by ATR-FTIR spectroscopy and molecular dynamics simulations. These hydrophilic nanotubes filled with a water wire facilitate not only the translocation of protons but also of monovalent cations as demonstrated by voltage-clamp experiments on black lipid membranes. Collectively, our results provide evidence that the natural fibupeptide lugdunin acts as a peptidic channel that is spontaneously formed by an intricate stacking mechanism, leading to the dissipation of a bacterial cell’s membrane potential.